Literature DB >> 12691827

Expression of heparanase in human tumor cell lines and human head and neck tumors.

Siro Simizu1, Keisuke Ishida, Michal K Wierzba, Taka Aki Sato, Hiroyuki Osada.   

Abstract

Heparanase is an endo-beta-D-glucuronidase that can cleave heparan sulfate and has been implicated in tumor angiogenesis and metastasis. Recent studies have demonstrated that overexpression of heparanase in human tumors facilitates their invasion activity, thereby enhancing the metastatic potential of the tumors. We found that heparanase mRNA and heparanase protein were constitutively elevated in some human tumor cell lines and human head and neck tumors. Heparanase mRNA expression was increased in response to treatment with an inhibitor of DNA methylation in cells that normally express low levels of heparanase mRNA. Inhibition of DNA methylation did not enhance heparanase mRNA expression in the presence of cycloheximide. These results suggest that overexpression of heparanase mRNA in cancer cells might not be due to demethylation of the promoter region of the heparanase gene itself, rather the other gene(s), such as transcriptional factors that, in turn, regulate heparanase expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691827     DOI: 10.1016/s0304-3835(02)00719-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.

Authors:  Ilana Doweck; Victoria Kaplan-Cohen; Inna Naroditsky; Edmond Sabo; Neta Ilan; Israel Vlodavsky
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

2.  A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.

Authors:  Laura Q M Chow; Daniel L Gustafson; Cindy L O'Bryant; Lia Gore; Michele Basche; Scott N Holden; Mark C Morrow; Stacy Grolnic; Brian R Creese; Kaye L Roberts; Kat Davis; Russell Addison; S Gail Eckhardt
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-05       Impact factor: 3.333

3.  Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.

Authors:  Xian-Jun Liang; Ling Yuan; Jie Hu; Hong-Hua Yu; Tao Li; Shao-Fen Lin; Shi-Bo Tang
Journal:  Mol Vis       Date:  2012-06-20       Impact factor: 2.367

4.  An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation.

Authors:  Xiaoyan Liu; Hong Fang; Hongchao Chen; Xiaoling Jiang; Deren Fang; Yan Wang; Dingxian Zhu
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

5.  Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo.

Authors:  Bushra Ateeq; Alexander Unterberger; Moshe Szyf; Shafaat A Rabbani
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

6.  Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma.

Authors:  Nir Hirshoren; Raanan Bulvik; Tzahi Neuman; Ariel M Rubinstein; Amichay Meirovitz; Michael Elkin
Journal:  J Cell Mol Med       Date:  2013-11-28       Impact factor: 5.310

Review 7.  Mammalian heparanase: what is the message?

Authors:  Veronique Vreys; Guido David
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

Review 8.  Radical-Mediated Enzymatic Polymerizations.

Authors:  Scott R Zavada; Tsatsral Battsengel; Timothy F Scott
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.